![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | abnormal bone remodeling | treatment | IMP | | 150520059 | | RGD | | abnormal hemostasis | treatment | IMP | | 150520060 | | RGD | | decreased circulating serum albumin level | | IMP | | 11530071 | as compared to wild type Sprague Dawley | RGD | | decreased circulating total protein level | | IMP | | 11530071 | as compared to wild type Sprague Dawley | RGD | | hemarthrosis | treatment | IMP | | 150520059; 150520060 | | RGD | | hemorrhage | | IMP | | 11530071 | | RGD | | increased bleeding time | treatment | IMP | | 150520060 | | RGD | | increased leukocyte cell number | | IMP | | 11530071 | as compared to wild type Sprague Dawley | RGD | | increased partial thromboplastin time | | IMP | | 11530071 | as compared to wild type Sprague Dawley | RGD | | joint inflammation | treatment | IMP | | 150520059 | | RGD | | thrombocytosis | | IMP | | 11530071 | as compared to wild type Sprague Dawley | RGD | | |